BMRN vs ROOT · P/E 40, rev $2.85B vs P/E 14, rev $1.18B
Biomarin Pharmaceutical Inc (BMRN) versus Root Inc (ROOT) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Root Inc (ROOT) is a insurance - property & casualty company listed on NASDAQ.
Latest reported BMRN revenue for 2024-12-31 was $2.85B. Net income was $426.9M. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported ROOT revenue for 2024-12-31 was $1.18B. Net income was $30.9M. Revenue was up 158.6% from 2023-12-31 to 2024-12-31. ROOT currently screens at market cap $767.6M and trailing P/E 14.3.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. ROOT currently screens at market cap $767.6M and trailing P/E 14.3.
Not investment advice. Open the BMRN and ROOT stock pages for the full models.
Not investment advice.